Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
22.33
-0.24 (-1.06%)
At close: Jul 19, 2024, 4:00 PM
23.30
+0.97 (4.34%)
Pre-market: Jul 22, 2024, 6:53 AM EDT
Bicycle Therapeutics Revenue
Bicycle Therapeutics had revenue of $41.61M in the twelve months ending March 31, 2024, with 168.47% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $19.53M with 298.90% year-over-year growth. In the year 2023, Bicycle Therapeutics had annual revenue of $26.98M with 86.52% growth.
Revenue (ttm)
$41.61M
Revenue Growth
+168.47%
P/S Ratio
22.88
Revenue / Employee
$146,514
Employees
284
Market Cap
951.99M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 26.98M | 12.51M | 86.52% |
Dec 31, 2022 | 14.46M | 2.77M | 23.65% |
Dec 31, 2021 | 11.70M | 1.31M | 12.58% |
Dec 31, 2020 | 10.39M | -3.41M | -24.72% |
Dec 31, 2019 | 13.80M | 6.67M | 93.40% |
Dec 31, 2018 | 7.14M | 5.08M | 246.41% |
Dec 31, 2017 | 2.06M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Avanos Medical | 680.10M |
CareDx | 275.11M |
BioLife Solutions | 137.30M |
Tango Therapeutics | 37.23M |
Silence Therapeutics | 33.86M |
AnaptysBio | 22.96M |
BCYC News
- 7 weeks ago - Bicycle Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting - Business Wire
- 2 months ago - Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing - Business Wire
- 2 months ago - Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results - Business Wire
- 3 months ago - Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting - Business Wire
- 3 months ago - Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference - Business Wire
- 4 months ago - Bicycle Therapeutics to Present at the AACR Annual Meeting 2024 - Business Wire
- 5 months ago - Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results - Business Wire